Financial Analysis: Competitive Technologies (OTCMKTS:CTTC) vs. Envoy Medical (NASDAQ:COCH)

Competitive Technologies (OTCMKTS:CTTC) and Envoy Medical (NASDAQ:COCH) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, profitability, risk, dividends, earnings and analyst recommendations.

Profitability

This table compares Competitive Technologies and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Competitive Technologies	N/A	N/A	N/A
Envoy Medical	-11,950.00%	N/A	-248.54%

Valuation & Earnings

This table compares Competitive Technologies and Envoy Medical”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Competitive Technologies	N/A	N/A	N/A	N/A	N/A
Envoy Medical	$220,000.00	101.60	-$20.80 million	($1.41)	-0.55

Competitive Technologies has higher earnings, but lower revenue than Envoy Medical.

Analyst Ratings

This is a summary of current ratings and price targets for Competitive Technologies and Envoy Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Competitive Technologies	0	0	0	0	0.00
Envoy Medical	1	0	1	0	2.00

Envoy Medical has a consensus target price of $9.50, suggesting a potential upside of 1,123.60%. Given Envoy Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Envoy Medical is more favorable than Competitive Technologies.

Institutional & Insider Ownership

8.6% of Envoy Medical shares are held by institutional investors. 17.5% of Competitive Technologies shares are held by company insiders. Comparatively, 5.7% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Envoy Medical beats Competitive Technologies on 5 of the 8 factors compared between the two stocks.

About Competitive Technologies

Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.